New Warning Labels for Opioids

FDA applies black-box warning to mixing opioids and benzodiazepines in an effort to prevent overdoses.

Opioid Label / Photo: Associated Press
Opioid Label / Photo: Associated Press

A recent CNN article discussed the FDA’s recent action to warn consumers of the dangers of mixing opioids and benzodiazepines. As the result of a citizen petition, the FDA has enforced black-box warnings, which is the highest-level warning. In the period from 2004 to 2011, the number of overdose deaths from mixing these two drugs has tripled, and the number of patients prescribed both a narcotic and a benzodiazepine has gone up 41%.

Now, when a patient gets their prescription filled, the bottle should have a notification that indicates a black-box warning for the drug, but the consumer will need to visit the manufacturer’s website for details. "It is nothing short of a public health crisis when you see a substantial increase of avoidable overdose and death related to two widely used drug classes being taken together,” said FDA Commissioner, Robert Califf.

Fresh from the show floor: pharma packaging innovations for 2026
Serialization mandates. Containment demands. Sterile barrier requirements. Our editors found the pharma packaging innovations addressing your biggest challenges at PACK EXPO Las Vegas. Get your free curated report now.
GET YOUR COPY
Fresh from the show floor: pharma packaging innovations for 2026